<Metabolites><creation_date>2005-11-16 15:48:42 UTC</creation_date><update_date>2020-02-27 20:29:42 UTC</update_date><accession>HMDB0000020</accession><name>p-Hydroxyphenylacetic acid</name><normal_concentrations><biospecimen>Blood</biospecimen><concentration_value>6.346 +/- 0.518</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>Before ingestion of water</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>6.695 +/- 0.555</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>2 h after ingestion of water</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>6.387 +/- 0.586</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>Before ingestion of quercetin</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>7.911 +/- 1</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>2 h after ingestion of 200 mg of quercetin</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>6.5 +/- 0.432</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>Before ingestion of (-)-epicathechin</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>6.661 +/- 0.692</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>2 h after ingestion of 200 mg of (-)-epicathechin</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>5.791 +/- 0.609</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>Before ingestion of epigallocatechin gallate</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>42.412 +/- 35.919</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Male</subject_sex><subject_condition>Normal</subject_condition><comment>2 h after ingestion of 200 mg of epigallocatechin gallate</comment><references><reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text><pubmed_id>19812218</pubmed_id></references><biospecimen>Blood</biospecimen><concentration_value>0.230 (0.070-0.390)</concentration_value><subject_age>Adult (&gt;18 years old)</subject_age><subject_sex>Both</subject_sex><subject_condition>Normal</subject_condition><references><reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text><pubmed_id /></references></normal_concentrations><abnormal_concentrations><biospecimen>Blood</biospecimen><concentration_value /><patient_age>Adult (&gt;18 years old)</patient_age><patient_sex>Female</patient_sex><patient_information>Breast cancer</patient_information><comment>By GC-MS </comment><references><reference /><reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text><reference /><pubmed_id>19783829</pubmed_id></references></abnormal_concentrations><diseases><disease><name>Schizophrenia</name><omim_id>181500</omim_id></disease><disease><name>Epilepsy</name><omim_id /></disease><disease><name>Colorectal cancer</name><omim_id>114500</omim_id></disease><disease><name>Ulcerative colitis</name><omim_id /></disease><disease><name>Crohn's disease</name><omim_id>266600</omim_id></disease><disease><name>Lung Cancer</name><omim_id>211980</omim_id></disease><disease><name>Spina Bifida</name><omim_id>182940</omim_id></disease><disease><name>Eosinophilic esophagitis</name><omim_id>610247</omim_id></disease><disease><name>Perillyl alcohol administration for cancer treatment</name><omim_id /></disease><disease><name>Fumarase deficiency</name><omim_id>606812</omim_id></disease><disease><name>Phenylketonuria</name><omim_id>261600</omim_id></disease></diseases></Metabolites>